Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
Science (New York, N.Y.)|September 13, 2008
Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heartChe-Hong Chen, Grant R Budas, Eric N Churchill, et al.
American Journal of Medical Genetics|May 1, 1984
Age at clinical onset and at ultrasonographic detection of adult polycystic kidney disease: data for genetic counsellingJ C Bear, P McManamon, J Morgan, et al.
The International Journal of Pediatric Nephrology|September 1, 1982
Acute renal failure in an infant with congenital neuroblastoma - successful treatment by hemodialysisS K Ali, L H Purchase, R F Kennedy, et al.
American Journal of Nephrology|January 1, 1992
Comparison of subcutaneous and intravenous recombinant human erythropoietin for anemia in hemodialysis patients with significant comorbid diseaseN Muirhead, D N Churchill, M Goldstein, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|January 1, 1987
Measurement of quality of life in end-stage renal disease: the time trade-off approachD N Churchill, G W Torrance, D W Taylor, et al.
Clinical Nephrology|March 1, 1995
Effect of recombinant human erythropoietin on hospitalization of hemodialysis patientsD N Churchill, N Muirhead, M Goldstein, et al.
Clinical Transplantation|December 17, 2013
Hypercalcemia in renal transplant patients: prevalence and management in Canadian transplant practiceN Muirhead, J S Zaltman, J S Gill, et al.
Journal of the American Society of Nephrology : JASN|April 1, 1994
Probability of thrombosis of vascular access among hemodialysis patients treated with recombinant human erythropoietinD N Churchill, N Muirhead, M Goldstein, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|December 9, 2010
Dialysis patients treated with Epoetin α show improved exercise tolerance and physical function: A new analysis of the Canadian Erythropoietin Study Group trialNorman Muirhead, Paul A Keown, David N Churchill, et al.
Kidney International|April 1, 1995
A controlled trial of cyclosporine in patients with progressive membranous nephropathy. Canadian Glomerulonephritis Study GroupD C Cattran, C Greenwood, S Ritchie, et al.
Pageof 9